266 related articles for article (PubMed ID: 28705001)
1. Epidemiology of pancreatic adenocarcinoma.
Simoes PK; Olson SH; Saldia A; Kurtz RC
Chin Clin Oncol; 2017 Jun; 6(3):24. PubMed ID: 28705001
[TBL] [Abstract][Full Text] [Related]
2. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
[TBL] [Abstract][Full Text] [Related]
3. Temporal trends of pancreatic ductal adenocarcinoma in young adults in the United States: A Population-Based Study.
Gad MM; Saad AM; Al-Husseini MJ; Abdel-Gawad YM; Alsalhani OM; Alhaddad R; Mohamad B; Saleh MA; Simons-Linares CR
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):204-210. PubMed ID: 31420297
[TBL] [Abstract][Full Text] [Related]
4. Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.
Yeo TP
Semin Oncol; 2015 Feb; 42(1):8-18. PubMed ID: 25726048
[TBL] [Abstract][Full Text] [Related]
5. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
Okabayashi T; Nishimori I; Maeda H; Hanazaki K
J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
[No Abstract] [Full Text] [Related]
6. Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.
Eibl G; Cruz-Monserrate Z; Korc M; Petrov MS; Goodarzi MO; Fisher WE; Habtezion A; Lugea A; Pandol SJ; Hart PA; Andersen DK;
J Acad Nutr Diet; 2018 Apr; 118(4):555-567. PubMed ID: 28919082
[TBL] [Abstract][Full Text] [Related]
7. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas.
Riall TS; Stager VM; Nealon WH; Townsend CM; Kuo YF; Goodwin JS; Freeman JL
J Am Coll Surg; 2007 May; 204(5):803-13; discussion 813-4. PubMed ID: 17481488
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammation in pancreatic cancer.
Hausmann S; Kong B; Michalski C; Erkan M; Friess H
Adv Exp Med Biol; 2014; 816():129-51. PubMed ID: 24818722
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma.
Date K; Ohtsuka T; Nakamura S; Mochidome N; Mori Y; Miyasaka Y; Oda Y; Nakamura M
Surgery; 2018 Feb; 163(2):291-299. PubMed ID: 29221879
[TBL] [Abstract][Full Text] [Related]
10. Multifocal cysts and incidence of pancreatic cancer concomitant with intraductal papillary mucinous neoplasm.
Ikegawa T; Masuda A; Sakai A; Toyama H; Zen Y; Sofue K; Nakagawa T; Shiomi H; Takenaka M; Kobayashi T; Yoshida M; Arisaka Y; Okabe Y; Kutsumi H; Fukumoto T; Azuma T
Pancreatology; 2018 Jun; 18(4):399-406. PubMed ID: 29685673
[TBL] [Abstract][Full Text] [Related]
11. Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis.
Howes N; Neoptolemos JP
Gut; 2002 Dec; 51(6):765-6. PubMed ID: 12427771
[No Abstract] [Full Text] [Related]
12. Diagnosis of pernicious anemia and the risk of pancreatic cancer.
Shah P; Rhim AD; Haynes K; Hwang WT; Yang YX
Pancreas; 2014 Apr; 43(3):422-6. PubMed ID: 24622073
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of intraductal papillary mucinous neoplasms of the pancreas: sex differences between 3 geographic regions.
Ingkakul T; Warshaw AL; Fernández-Del Castillo C
Pancreas; 2011 Jul; 40(5):779-80. PubMed ID: 21673537
[No Abstract] [Full Text] [Related]
14. Pancreatic cancer: epidemiology and risk factors.
Krejs GJ
Dig Dis; 2010; 28(2):355-8. PubMed ID: 20814212
[TBL] [Abstract][Full Text] [Related]
15. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
Al Haddad AH; Adrian TE
Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology of pancreatic ductal adenocarcinoma].
Sato R; Kishiwada M; Isaji S
Nihon Rinsho; 2015 Mar; 73 Suppl 3():95-9. PubMed ID: 25856992
[No Abstract] [Full Text] [Related]
17. Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study.
Xiao Q; Jones RR; James P; Stolzenberg-Solomon RZ
Cancer Res; 2021 Mar; 81(6):1616-1622. PubMed ID: 33514513
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and geographic distribution of BRCA1-2 and DNA Damage response genes pathogenic variants in pancreatic ductal adenocarcinoma patients.
Macchini M; Centonze F; Peretti U; Orsi G; Militello AM; Valente MM; Cascinu S; Reni M
Cancer Treat Rev; 2022 Mar; 104():102357. PubMed ID: 35184001
[TBL] [Abstract][Full Text] [Related]
19. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?
Vullierme MP; Lagadec M
Diagn Interv Imaging; 2016 Dec; 97(12):1233-1240. PubMed ID: 27816353
[TBL] [Abstract][Full Text] [Related]
20. Imaging of pancreatic neoplasms.
Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
